跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,671 条关于
“Sofinnova Investments”
全部
1,671
临床试验
14
药物
1
机构
40
资讯
1,616
去年
Artbio Raises $132 Million Series B to Advance Lead-212 Radiopharmaceutical for Prostate Cancer
11个月前
Expedition Therapeutics Secures $165 Million Series A to Advance First-in-Class DPP1 Inhibitor for COPD
4个月前
Coultreon Biopharma Secures $125M Series A to Advance Novel SIK3 Inhibitor for Autoimmune Diseases
去年
Seaport Therapeutics Secures $225M Series B to Advance Novel Neuropsychiatric Drug Pipeline
去年
Sofinnova Partners Secures €1.2 Billion to Fuel Next Wave of Biotech Innovation
12个月前
Avenzo Therapeutics Secures $60 Million Series B to Advance Next-Generation Oncology Pipeline
去年
Sofinnova Partners and NVIDIA Launch AI Infrastructure Partnership to Accelerate European Life Sciences Innovation
上个月
Expedition Therapeutics Raises $115M Series B as DPP1 Inhibitor EXPD-101 Enters Phase 2 COPD Trial
去年
Candel Therapeutics Strengthens Board with Industry Veteran Ahead of Key BLA Submission
上个月
Expedition Therapeutics Raises $115M Series B to Advance First Global Phase 2 Trial of DPP1 Inhibitor in COPD
第 1 页,共 162 页
上一页
下一页